Personalized mRNA Vaccine Cuts Melanoma Risk by 42%
Moderna and Merck report that a personalized mRNA vaccine plus Keytruda reduced melanoma recurrence or death risk by 42%, but full trial details remain pending.
Moderna and Merck report that a personalized mRNA vaccine plus Keytruda reduced melanoma recurrence or death risk by 42%, but full trial details remain pending.
New Mexico’s attorney general says Meta’s reported $25 billion ruling could encourage broader state enforcement of AI, privacy, consumer-protection, and technology laws.
SpaceX is reportedly discussing access to up to 80,000 U.S. cell sites for a possible wireless network that could combine terrestrial coverage with Starlink satellite connectivity.
Project Helix could reportedly cost $1,200 to $1,800, but a premium Xbox makes more sense as a flagship alongside cheaper consoles, handhelds, PCs, and cloud gaming.
Treasury yields suffered their steepest one-day decline since the 2023 banking crisis. Here is what the move may signal for rates, growth, markets, and investors.
Reported homebrew access represents an early security setback for Nintendo’s Switch 2, but it does not yet prove a full jailbreak or piracy breakthrough.
An alleged Mass Effect 5 trailer featuring Liara T’Soni has reportedly surfaced after BioWare closure reports, but its authenticity and the game’s status remain unconfirmed.
Apple’s reported iPhone Duo strategy may be increasing interest in Samsung’s Galaxy Z8, although current evidence does not prove a specific sales increase.
Flu activity is rising earlier than usual in parts of the US West Coast. Learn what this means, who faces greater risks, and why vaccination still matters.
A measles outbreak in Pennsylvania could spread beyond the United States through travel, uneven vaccination coverage, and delayed detection. Learn how prevention limits wider transmission.